Tom Nolan reviews this week’s research GLP-1 receptor agonists, now widely used for diabetes, cardiovascular disease, and weight loss, seem to be as effective for these indications regardless of age, ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results